Financial cost of treating out-patients with schizophrenia in Nigeria.
Background An assessment of the monetary costs oftreating a group of Nigerian out-patients with schizophrenia, in comparison with insulin-dependent diabetics, was made.
Method Fifty out-patients with schizophrenia (mean age 42.9) and 40 with diabetes (mean age 41.9), attending government hospitals in Lagos, were assessed at six-monthly intervals, for direct and indirect costs (US$=82 naira ; minimum monthly wage=500 naira).
Results Twenty (40%) of those with schizophrenia and eight (20%) ofthe diabetics had no income at all.
The mean total cost of schizophrenia six months (2951.4 naira) or US$ 35.9) was significantly less than that of diabetes (11 791 naira or US$ 143).
The cost of antipsychotic drugs accounts for 52.8% ofthe cost of schizophrenia ; insulin injections accounted for 92.8% of the total cost of diabetes.
Patients with schizophrenia and their relatives suffered significantly more loss of working days.
Cost of illness was not significantly correlated with age and duration of illness.
Conclusions Because ofdrastic currency devaluation, and lackofdisability benefits and nursing homes, the findings contrast with Western reports where cost ofdrugs constitutes 2-5%, and indirect costs constitute over 50% ofthe total cost of schizophrenia.
Mots-clés Pascal : Schizophrénie, Psychose, Traitement communautaire, Ambulatoire, Psychiatrie communautaire, Nigéria, Afrique, Analyse coût, Economie santé, Homme
Mots-clés Pascal anglais : Schizophrenia, Psychosis, Community treatment, Ambulatory, Community psychiatry, Nigeria, Africa, Cost analysis, Health economy, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0529085
Code Inist : 002B18H05B. Création : 13/02/1998.